Pancreatic Cancer - Pipeline Review, H2 2018
SKU ID :GMD-12956099 | Published Date: 21-Dec-2018 | No. of pages: 2787Description
TOC
Table of Contents
Table of Contents 2
Introduction 14
Pancreatic Cancer - Overview 15
Pancreatic Cancer - Therapeutics Development 16
Pancreatic Cancer - Therapeutics Assessment 94
Pancreatic Cancer - Companies Involved in Therapeutics Development 135
Pancreatic Cancer - Drug Profiles 289
Pancreatic Cancer - Dormant Projects 2665
Pancreatic Cancer - Discontinued Products 2694
Pancreatic Cancer - Product Development Milestones 2700
Appendix 2711
Tables & Figures
List of Tables
Number of Products under Development for Pancreatic Cancer, H2 2018 91
Number of Products under Development by Companies, H2 2018 93
Number of Products under Development by Universities/Institutes, H2 2018 118
Products under Development by Companies, H2 2018 123
Products under Development by Universities/Institutes, H2 2018 163
Number of Products by Stage and Target, H2 2018 170
Number of Products by Stage and Mechanism of Action, H2 2018 188
Number of Products by Stage and Route of Administration, H2 2018 206
Number of Products by Stage and Molecule Type, H2 2018 209
Pancreatic Cancer - Pipeline by 3-V Biosciences Inc, H2 2018 210
Pancreatic Cancer - Pipeline by 4P-Pharma SAS, H2 2018 210
Pancreatic Cancer - Pipeline by 4SC AG, H2 2018 211
Pancreatic Cancer - Pipeline by AB Science SA, H2 2018 211
Pancreatic Cancer - Pipeline by AbbVie Inc, H2 2018 212
Pancreatic Cancer - Pipeline by AbGenomics International Inc, H2 2018 212
Pancreatic Cancer - Pipeline by Ability Pharmaceuticals SL, H2 2018 213
Pancreatic Cancer - Pipeline by Aclaris Therapeutics Inc, H2 2018 213
Pancreatic Cancer - Pipeline by Actuate Therapeutics Inc, H2 2018 214
Pancreatic Cancer - Pipeline by Adamed Sp z oo, H2 2018 214
Pancreatic Cancer - Pipeline by ADC Therapeutics SA, H2 2018 214
Pancreatic Cancer - Pipeline by Aduro BioTech Inc, H2 2018 215
Pancreatic Cancer - Pipeline by Advanced BioDesign, H2 2018 215
Pancreatic Cancer - Pipeline by Advantagene Inc, H2 2018 216
Pancreatic Cancer - Pipeline by Advanz Pharmaceutical Corp , H2 2018 216
Pancreatic Cancer - Pipeline by Advenchen Laboratories LLC, H2 2018 217
Pancreatic Cancer - Pipeline by Agency for Science, Technology and Research, H2 2018 217
Pancreatic Cancer - Pipeline by AGV Discovery SAS, H2 2018 217
Pancreatic Cancer - Pipeline by AIMM Therapeutics BV, H2 2018 218
Pancreatic Cancer - Pipeline by Alissa Pharma, H2 2018 218
Pancreatic Cancer - Pipeline by Alligator Bioscience AB, H2 2018 219
Pancreatic Cancer - Pipeline by Allinky Biopharma SL, H2 2018 219
Pancreatic Cancer - Pipeline by Almac Discovery Ltd, H2 2018 219
Pancreatic Cancer - Pipeline by Altor BioScience Corp, H2 2018 220
Pancreatic Cancer - Pipeline by ALX Oncology Inc, H2 2018 220
Pancreatic Cancer - Pipeline by Ambrx Inc, H2 2018 220
Pancreatic Cancer - Pipeline by amcure GmbH, H2 2018 221
Pancreatic Cancer - Pipeline by Amgen Inc, H2 2018 221
Pancreatic Cancer - Pipeline by Amplia Therapeutics Ltd, H2 2018 222
Pancreatic Cancer - Pipeline by Anavex Life Sciences Corp, H2 2018 222
Pancreatic Cancer - Pipeline by Andarix Pharmaceuticals Inc, H2 2018 223
Pancreatic Cancer - Pipeline by ANP Technologies Inc, H2 2018 223
Pancreatic Cancer - Pipeline by AntiCancer Inc, H2 2018 223
Pancreatic Cancer - Pipeline by APEIRON Biologics AG, H2 2018 224
Pancreatic Cancer - Pipeline by Apexigen Inc, H2 2018 224
Pancreatic Cancer - Pipeline by Aphios Corp, H2 2018 224
Pancreatic Cancer - Pipeline by Aposense Ltd, H2 2018 225
Pancreatic Cancer - Pipeline by Aravive Inc, H2 2018 225
Pancreatic Cancer - Pipeline by ArQule Inc, H2 2018 226
Pancreatic Cancer - Pipeline by Array BioPharma Inc, H2 2018 226List of Figures
Number of Products under Development for Pancreatic Cancer, H2 2018 91
Number of Products under Development by Companies, H2 2018 92
Number of Products under Development by Universities/Institutes, H2 2018 118
Number of Products by Top 10 Targets, H2 2018 169
Number of Products by Stage and Top 10 Targets, H2 2018 169
Number of Products by Top 10 Mechanism of Actions, H2 2018 187
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018 187
Number of Products by Top 10 Routes of Administration, H2 2018 205
Number of Products by Stage and Top 10 Routes of Administration, H2 2018 205
Number of Products by Top 10 Molecule Types, H2 2018 208
Number of Products by Stage and Top 10 Molecule Types, H2 2018 208
Companies
3-V Biosciences Inc
4P-Pharma SAS
4SC AG
AB Science SA
AbbVie Inc
AbGenomics International Inc
Ability Pharmaceuticals SL
Aclaris Therapeutics Inc
Actuate Therapeutics Inc
Adamed Sp z oo
ADC Therapeutics SA
Aduro BioTech Inc
Advanced BioDesign
Advantagene Inc
Advanz Pharmaceutical Corp
Advenchen Laboratories LLC
Agency for Science, Technology and Research
AGV Discovery SAS
AIMM Therapeutics BV
Alissa Pharma
Alligator Bioscience AB
Allinky Biopharma SL
Almac Discovery Ltd
Altor BioScience Corp
ALX Oncology Inc
Ambrx Inc
amcure GmbH
Amgen Inc
Amplia Therapeutics Ltd
Anavex Life Sciences Corp
Andarix Pharmaceuticals Inc
ANP Technologies Inc
AntiCancer Inc
APEIRON Biologics AG
Apexigen Inc
Aphios Corp
Aposense Ltd
Aravive Inc
ArQule Inc
Array BioPharma Inc
Asana BioSciences LLC
Ascelia Pharma AB
Astellas Pharma Inc
AstraZeneca Plc
Aurigene Discovery Technologies Ltd
AVEO Pharmaceuticals Inc
Axcentua Pharmaceuticals AB
Basilea Pharmaceutica Ltd
Batu Biologics Inc
Bavarian Nordic A/S
Bayer AG
BeiGene Ltd
Bellicum Pharmaceuticals Inc
Berg LLC
BerGenBio ASA
Bexion Pharmaceuticals LLC
BeyondSpring Inc
Bio-Path Holdings Inc
BioAtla LLC
Biokine Therapeutics Ltd
BioLineRx Ltd
BioMoti Ltd
Biomunex Pharmaceuticals
Biothera Pharmaceutical Inc
Biouniversa srl
BioXcel Therapeutics Inc
BLR Bio LLC
Boehringer Ingelheim GmbH
Boston Biomedical Inc
BriaCell Therapeutics Corp
Bristol-Myers Squibb Co
Cancer Prevention Pharmaceuticals Inc
Canget BioTekpharma LLC
Cantargia AB
Cantex Pharmaceuticals Inc
CARsgen Therapeutics Ltd
CBM BioPharma Inc
CBT Pharmaceuticals Inc
CCRP Therapeutics GmbH
Celgene Corp
Celldex Therapeutics Inc
Cellectar Biosciences Inc
Celleron Therapeutics Ltd
Cellular Biomedicine Group Inc
Celprogen Inc
Celyad SA
Centrose LLC
ChemoCentryx Inc
Chugai Pharmaceutical Co Ltd
Clovis Oncology Inc
COARE Biotechnology Inc
Codiak BioSciences Inc
Corcept Therapeutics Inc
Cotinga Pharmaceuticals Inc
CPL Biologicals Pvt Ltd
CrystalGenomics Inc
CTI BioPharma Corp
Cyclacel Pharmaceuticals Inc
CytImmune Sciences Inc
Cytori Therapeutics Inc
CyTuVax BV
Daiichi Sankyo Co Ltd
DEKK-TEC Inc
Delta-Fly Pharma Inc
Denceptor Therapeutics Ltd
Diffusion Pharmaceuticals Inc
Eisai Co Ltd
Eleison Pharmaceuticals LLC
Eli Lilly and Co
Endor Technologies SL
Enterome Bioscience SA
Erytech Pharma SA
Esperance Pharmaceuticals Inc
Etubics Corp
Exelixis Inc
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Felicitex Therapeutics Inc
FibroGen Inc
Forbius
Formosa Laboratories Inc
- PRICE
-
$2500$7500